Clinical Trial Update: Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the efficacy and safety of mycophenolate mofetil in Chinese patients with neuromyelitis optica spectrum disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorder

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Neuromyelitis Optica Spectrum Disorders, Mycophenolate Mofetil | Phase 4 | Status: UNKNOWN